首页> 美国卫生研究院文献>British Journal of Cancer >A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation interpretations and limitations.
【2h】

A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation interpretations and limitations.

机译:灵敏的酶联免疫吸附测定法用于定量分析头颈癌中的表皮生长因子受体蛋白:评估解释和局限性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the receptor was overexpressed in head and neck squamous cell carcinomas compared with the normal counterpart, and to establish whether clinicopathological correlations were present by investigating a broad spectrum of parameters (tumour size, clinical stage, positive lymph nodes, tumour site, histological grade, keratinisation, preoperative irradiation and clinical outcome). The assay employs two commercially available monoclonal antibodies, both detecting protein epitopes. The material comprises 60 head and neck carcinomas, corresponding normal tissue and normal oral mucosa from healthy individuals. The study demonstrates significantly higher receptor levels in tumours compared with normal tissue (P < 0.002) and a range in tumours and normal tissues of 0.4-10.5 and 0.1-4.3 nmol g-1 membrane protein respectively. Quantitation of receptors in normal mucosa emphasises the importance of using the patients' corresponding normal tissue, because using the patients' mucosa resulted in 83% overexpression, while using normal mucosa from healthy individuals only demonstrated overexpression in 50% of cases. No significant clinicopathological correlations could be established, although the mean values for EGFR increased with tumour size and advanced clinical stage. Furthermore, the prognostic value concerning disease-free survival, recurrence and the time interval for recurrence were investigated but no significance could be demonstrated. In conclusion, the investigation supports the theory of overexpression of EGFR protein as a common motif for malignant epithelial tumours, but limitations in interpretations are demonstrated and discussed further.
机译:EGF受体是一种跨膜糖蛋白,对上皮细胞产生促有丝分裂作用。本研究的目的是开发一种敏感的酶联免疫吸附测定(ELISA)方法,用于测定表皮生长因子受体(EGFR)蛋白,以检查该受体在头颈部鳞状细胞癌中与正常人相比是否过表达,并通过调查各种参数(肿瘤大小,临床分期,淋巴结阳性,肿瘤部位,组织学分级,角化,术前放疗和临床结果)来确定是否存在临床病理相关性。该测定法使用两种可商购的单克隆抗体,均检测蛋白表位。该材料包括来自健康个体的60例头颈癌,相应的正常组织和正常口腔粘膜。该研究表明,与正常组织相比,肿瘤中的受体水平显着更高(P <0.002),肿瘤和正常组织中的受体水平分别为0.4-10.5和0.1-4.3 nmol g-1膜蛋白。正常粘膜中受体的定量强调了使用患者相应的正常组织的重要性,因为使用患者粘膜会导致83%的过表达,而使用健康人的正常粘膜只会在50%的情况下显示出过表达。尽管EGFR的平均值随肿瘤的大小和临床分期的增加而增加,但仍未建立明显的临床病理相关性。此外,研究了关于无病生存,复发和复发时间间隔的预后价值,但未显示出显着意义。总之,该研究支持EGFR蛋白过表达作为恶性上皮肿瘤的常见基元的理论,但解释的局限性得到了证明和进一步讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号